Clinical Trials Directory

Trials / Sponsors / Guangzhou JOYO Pharma Co., Ltd

Guangzhou JOYO Pharma Co., Ltd

Industry · 12 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingJYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs
Non Small Cell Lung Cancer
Phase 32025-09-23
RecruitingStudy of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
Phase 22025-03-31
Enrolling By InvitationA Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Phase 22023-12-27
RecruitingSC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2 / Phase 32023-06-06
RecruitingA Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (
Neuromyelitis Optica Spectrum Disorders
Phase 22023-05-24
CompletedSafety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
Idiopathic Pulmonary Fibrosis
Phase 12022-08-11
RecruitingPhase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Neoplasms
Phase 12022-05-04
CompletedEvaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
Healthy Subjects
Phase 12021-09-26
CompletedThe Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.
Diopathic Pulmonary Fibrosis, Pulmonary Fibrosis
Phase 12021-06-03
CompletedMultiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolem
Hypercholesterolemia
Phase 12021-04-01
CompletedAscending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment
Hyperlipidemia
Phase 12020-09-25
CompletedEvaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults
Healthy Subjects
Phase 12020-08-18